Here, we examined if trastuzumab binds to HER2-positive breast cancer cell lines including SKBR3, BT474, MCF7, and MDA-MB-231 by double immunofluorescence staining of HER2 and trastuzumab (Figure 1). The gene discussed is ERBB2; the disease is breast cancer.